Phreesia stock fell 6.58% after Raymond James analyst John Ransom downgraded the company from outperform to market perform. The downgrade was triggered by concerns over declining organic revenue growth that could turn negative in H2, combined with worries about AI spending pressuring EBITDA and potential budget constraints among healthcare provider customers. Despite 10% YoY revenue growth and nearly tripled profitability in Q2, the company missed earnings expectations.

Phreesia (PHR) stock fell 6.33% after reporting Q2 fiscal 2027 earnings that missed analyst expectations on net income despite beating revenue estimates. While the company posted strong net income growth to $1.9 million ($0.03 per share) and 10% revenue growth to $129.5 million, analysts expected $0.09 per share in earnings. The company maintained full-year guidance and highlighted new products AccessOne and ProviderConnect, but the analyst recommends holding off on investment given the modest performance and ongoing restructuring.

Phreesia reported Q3 2026 earnings of $0.03 per share, missing consensus estimates of $0.11 by 72.73%, though revenues slightly missed expectations at $129.46M. The stock has underperformed the S&P 500 by 41.5% year-to-date. With a Zacks Rank #3 (Hold) rating and mixed estimate revisions, the stock is expected to perform in line with the market near-term.

A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while experiencing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May 8, 2025 to March 30, 2026.

Rosen Law Firm, an investor rights law firm, is notifying shareholders of Microsoft Corporation and other companies about important deadlines for joining securities class action lawsuits. The firm alleges that Microsoft made false statements regarding its Copilot product line's performance issues, competitive positioning, and failure to convert users to paid subscriptions, resulting in investor losses.

Rosen Law Firm is reminding Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of the July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor damages.

Bernstein Liebhard LLP has announced an investigation into whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company. The investigation targets shareholders who purchased shares prior to May 8, 2025. The law firm is seeking affected shareholders to discuss their legal rights and options.

The Schall Law Firm is seeking investors who purchased Phreesia, Inc. securities between May 8, 2025 and March 30, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements regarding its long-term growth outlook and fiscal year 2027 projections, particularly regarding pharmaceutical marketing commitments as a growth driver for its Network Solutions segment.

A securities class action lawsuit has been filed against Phreesia, Inc. for allegedly making false and misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Investors who purchased stock between May 8, 2025 and March 30, 2026 and suffered losses exceeding $100,000 are encouraged to join the class action before the July 13, 2026 lead plaintiff deadline.

Rosen Law Firm is reminding investors in Phreesia, Inc. who purchased common stock between May 8, 2025 and March 30, 2026 of an important July 13, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Phreesia made false statements and concealed material negative facts regarding declining demand and reduced transparency in revenue sources, particularly in its network solutions segment. Investors who suffered losses exceeding $100,000 are encouraged to seek legal representation.

A class action lawsuit has been filed against Phreesia Inc. for allegedly misleading investors about revenue growth projections and risks in its Network Solutions segment. The company announced significantly lowered fiscal 2027 revenue guidance on March 30, 2026, causing the stock to plummet 26.6%. The deadline to file a lead plaintiff motion is July 13, 2026.

Rosen Law Firm is notifying investors in Phreesia, Roblox, and Zoetis of ongoing securities class action lawsuits. Phreesia investors who purchased stock between May 8, 2025 and March 30, 2026 are reminded of the July 13, 2026 lead plaintiff deadline. The lawsuit alleges that Phreesia made false statements regarding slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.